Eli Lilly

Eli Lilly accounts for 14 tracked companies with verified cap-table data, 14 of which disclose round sizes totalling $2.3B. The median disclosed raise is $95M, and the largest is NewLimit at $682M, ahead of AdvanCell ($440M) and Iterative Health ($195M).

The names that recur most often on these co-invested cap tables are Eli Lilly (14 companies), Khosla Ventures (3 companies), Abingworth (2 companies), Johnson & Johnson (2 companies), Founders Fund (1 company), Kleiner Perkins (1 company). By latest disclosed round, the market skews Series A (5), Series C (3), Series B (3), Series D (1).

• Companies tracked: 14
• Disclosed funding total: $2.3B across 14 companies
• Median disclosed raise: $95M
• Largest raise: NewLimit — $682M
• Stage mix: Series A 5 · Series C 3 · Series B 3 · Series D 1
• Most recent dated round: 2026-06-01

Best funded Eli Lilly companies

1. NewLimit — $682M (latest: Series C)
2. AdvanCell — $440M (latest: Series D)
3. Iterative Health — $195M (latest: Series C)
4. Verge Genomics — $180M (latest: Seed)
5. Ampersand Biomedicines — $165M (latest: Series B)
6. Nido Biosciences — $109M (latest: Series B)
7. Excelsior Development — $95M (latest: Series A)
8. Stylus Medicine — $85M (latest: Series A)
9. Ionetix — $85M (latest: Series F)
10. Faze Medicines — $81M (latest: Series A)
11. AltPep — $76M (latest: Series B)
12. GenEdit — $59M (latest: Series A)
13. MiNA Therapeutics — $45M (latest: Series A)
14. Seraxis — $40M (latest: Series C)

Eli Lilly — related firms and companies (56)

• NewLimit
• AdvanCell
• Iterative Health
• Verge Genomics
• Ampersand Biomedicines
• Nido Biosciences
• Excelsior Development
• Stylus Medicine
• Investors like Torch Capital
• MiNA Therapeutics
• Investors like Greylock
• Investors like Insight Partners
• Investors like Amino Capital
• Investors like Soma Capital
• Faze Medicines
• Investors like Goldman Sachs
• Investors like Matrix
• Investors like The Westly Group
• Investors like 137 Ventures
• Investors like QED Investors
• Investors like Service Provider Capital
• Investors like Maveron
• Eli Lilly portfolio companies 2026
• Investors like Bessemer Venture Partners
• Investors like Bienville Capital
• Investors like GSR Ventures
• Investors like Techstars Ventures
• GenEdit
• Investors like 500 Global
• Investors like Google Ventures
• Investors like Ribbit Capital
• Investors like StepStone Group
• Ionetix
• Investors like DCVC
• Investors like General Atlantic
• Companies backed by Eli Lilly
• Investors like Oak HC/FT
• Investors like Ventioneers
• Investors like Western Technology Investment
• Investors like RRE Ventures
• Seraxis
• Investors like First Round Capital
• Investors like Khosla Ventures
• Investors like Alexandria Venture Investments
• Investors like F-Prime
• AltPep
• Investors like Upfront Ventures
• Investors like Gaingels
• Investors like Altos Ventures
• Investors like Recursive Ventures
• Investors like Shasta Ventures
• Investors like Scale Venture Partners
• Investors like Benchmark
• Investors like Eli Lilly
• Investors like Blockchain Capital
• Investors like GIC

Eli Lilly alternatives · All research reports